Form 4: BioLife Solutions Executive Sells Shares Under 10b5-1 Trading Plan

Sarah Aebersold, Chief Human Resources Officer of BioLife Solutions, sold shares of common stock under pre-arranged 10b5-1 trading plans.

Summary

• On March 11, 2025, Sarah Aebersold, Chief Human Resources Officer of BioLife Solutions Inc., sold 1,091 shares of common stock at a price of $25 per share.
• On March 12, 2025, Aebersold sold 7,324 shares of common stock at a price of $26.34 per share.
• These sales were executed under Rule 10b5-1(c) trading plans adopted on March 8, 2024, and December 11, 2024.
• Following these transactions, Aebersold beneficially owns 51,492 shares of BioLife Solutions Inc.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports stock sales under a pre-existing trading plan, which is a common practice.

Industry Context

This is a routine disclosure of insider trading activity. It is common for executives to use 10b5-1 trading plans to sell shares over time to avoid accusations of trading on inside information. The sales themselves don't necessarily indicate a negative outlook for the company.

Stakeholder Impact

• The stock sales could have a minor negative impact on shareholder sentiment, but the impact is likely to be minimal given the pre-planned nature of the transactions.

Key Dates